The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.

@article{Birnkrant2009TheEU,
  title={The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.},
  author={D. Birnkrant and E. Cox},
  journal={The New England journal of medicine},
  year={2009},
  volume={361 23},
  pages={
          2204-7
        }
}
On October 23 the FDA issued an Emergency Use Authorization for peramivir for the treatment of suspected or confirmed cases of 2009 H1N1 influenza. Drs. Debra Birnkrant and Edward Cox discuss the limited data on safety and efficacy and the criteria for emergency use of peramivir. 
The Emergency Use Authorization of Peramivir IV: A View from the Manufacturer
Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States
Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.
  • A. Sorbello, S. Jones, +14 authors G. D. Dal Pan
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.
  • Yon C Yu, S. Garg, +5 authors T. Uyeki
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
Emergency authorization of medical products: regulatory challenges from the 2009 H1N1 influenza pandemic in Japan.
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
...
1
2
3
4
5
...